2nd Quarter - Report

ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$75,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 19, 2017 $75,000 Replaced
2nd Quarter - Amendment Jul 24, 2019 $75,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

American Health Care Act (H.R. 1628) BCRA (Better Care Reconciliation Act) S989 Ensuring Childrens Access to Specialty Care Act HR 2999 Patients Access to Treatments Act HR 2077 Restoring the Patients Voice Act HR 2430, S 934 FDA Reauthorization Act HR 1703, Medical Product Communications Act of 2017

LobbyistCovered position, as disclosed
ANNA HYDE Vice President, Advocacy and Access
VINCENT PACILEO Director, Federal Affairs
SANDIE J. PREISS —

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA)

Bills named: H.R. 2430 (115th), H.R. 2999 (115th), H.R. 1703 (115th), H.R. 1628 (115th), H.R. 2077 (115th)

Budget/Appropriations BUD

Budget Control Act FY17 Appropriations for HHS FY17 Appropriations for DoD FY17 Appropriations for VA FY18 Appropriations for DoD FY18 Appropriations for HHS FY18 Appropriations for VA Bipartisan Budget Act of 2015

LobbyistCovered position, as disclosed
ANNA HYDE Vice President, Advocacy and Access
VINCENT PACILEO Director, Federal Affairs
SANDIE J. PREISS —

Contacted: SENATE; Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

n/a

Foreign entity interest: C-THRU S637 HR 1316 Prescription Drug Price Transparency Act Part B Part D Medicaid

LobbyistCovered position, as disclosed
ANNA HYDE Vice President, Advocacy and Access
VINCENT PACILEO Director, Federal Affairs
SANDIE J. PREISS —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.